Prescription drug · NDA
Bloxiverz (Neostigmine methylsulfate) NDC 51754-1200
Neostigmine methylsulfate 1 mg/mL · Injection · Intravenous · Exela Pharma Sciences, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51754-1200-3 | 5175412000351754120003 | 10 SYRINGE, PLASTIC in 1 CARTON (51754-1200-3) / 5 mL in 1 SYRINGE, PLASTICMarketed from Dec 31, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Bloxiverz
- Generic name (nonproprietary)
- neostigmine methylsulfate
- Active ingredients
- Neostigmine methylsulfate — 1 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Exela Pharma Sciences, LLCNDC labeler code 51754
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 204078
- Marketing start
- Listing expires
- Other FDA classes
- Cholinesterase Inhibitors (Mechanism)
- Identifiers
- Product ID 51754-1200_f9ddedaa-a4a1-4fa2-8a3e-a3bb3abdde47SPL ID f9ddedaa-a4a1-4fa2-8a3e-a3bb3abdde47SPL set ID d2f55643-2b0d-4ef9-a9d8-b7138b314372RxCUI 311935, 311936, 1429282, 1429284, 1668225, 2673236UNII 98IMH7M386
- Pharmacologic class
- Cholinesterase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N451754120003followed by a unit qualifier and the quantityPackage 51754-1200-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
BLOXIVERZ, is a cholinesterase inhibitor, indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. BLOXIVERZ, is a cholinesterase inhibitor, indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery ( 1 ).
Excerpt only. Read the full label for complete information.
About NDC 51754-1200
- What is NDC 51754-1200?
- 51754-1200 is the product NDC for Bloxiverz (neostigmine methylsulfate), Neostigmine methylsulfate 1 mg/mL injection, listed with the FDA by Exela Pharma Sciences, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Bloxiverz (Neostigmine Methylsulfate).
- What is the active ingredient?
- Neostigmine methylsulfate.
- Who is the labeler?
- Exela Pharma Sciences, LLC, NDC labeler code 51754. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Bloxiverz?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.